Polar Asset Management Partners’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Polar Asset Management Partners’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,000	Closed	-$4.95M	–	1441
2021 Q2	$4.95M	Hold	20,000	–	–	0.05%	375
2021 Q1	$4.87M	Buy	+20,000	New	+$4.91M	0.05%	354

Other funds holding EFTR

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Polar Asset Management Partners's EFTR Position: Q3 2021 in Review

Polar Asset Management Partners sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2021, closing a stake of 20,000 shares — an estimated $4.95M sold.

Polar Asset Management Partners first reported a position in EFTR in Q1 2021 and held it in 2 quarters. The position peaked at $4.95M in Q2 2021. 12 funds tracked by Wall St. Rank hold EFTR as of Q3 2021.

Polar Asset Management Partners reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Polar Asset Management Partners sold 20,000 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $4.95M.
Polar Asset Management Partners first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
Polar Asset Management Partners's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $4.95M in Q2 2021.
12 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Polar Asset Management Partners's 13F filing for Q3 2021, filed 15 Nov 2021.